InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+14.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Heyman Tomas J., Director. Insider active across 2 companies, notably Akero Therapeutics, Inc.. Cumulatively, 7 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €178k. History available since 31 May 2023. The latest transaction was disclosed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations7 total
8,367 shares0Common StockSEC:0000939767-26-000082:0
9,398 sharesCommon StockSEC:0001193125-25-312134
9,398 sharesCommon StockSEC:0001193125-25-312134:0
4,544 shares@ US$44.29100.0% of flowCommon StockSEC:0000939767-25-000084:0
18,838 shares0Common StockSEC:0000939767-24-000099:0
26,000 shares@ US$25.04100.0% of flowCommon StockSEC:0000950170-23-029231:0
18,176 shares0Common StockSEC:0000939767-23-000065:0
7 of 7 declarations
About Heyman Tomas J.
Tomas J. Heyman is a Director at Akero Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His expertise in the biopharmaceutical sector is essential for guiding Akero towards innovation and growth.
